Results 231 to 240 of about 195,389 (268)

„Valve-in-valve-in-valve-in-valve“ …?

Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2018
Die „Valve-in-valve“-Therapie ist eine kathetergefuhrte Methode zur Behandlung von Fehlfunktionen chirurgischer Herzklappenbioprothesen. Dabei wird eine Transkatheterklappe am schlagenden Herzen in eine zuvor implantierte Bioprothese eingesetzt. Der vorliegende Beitrag zeigt Indikationen, Besonderheiten und Limitationen dieses Verfahrens auf.
openaire   +1 more source

Redo surgical aortic valve replacement for prosthetic valve valve‐in‐valve dysfunction

Journal of Cardiac Surgery, 2022
Transcatheter aortic valve replacement (TAVR) has become the preferred intervention for patients with severe aortic stenosis and significant comorbidities. This technique can also be used for failed bioprosthetic valves and is known as the valve-in-valve (ViV) procedure. Placing TAVR in a small bioprosthesis (
Giuseppe Tavilla, Amber Malhotra, Brady Gunn, Daniel L. Beckles, Ramachandra C. Reddy   +4 more
openaire   +2 more sources

Transcatheter valve-in-valve Implantation for Failing Bioprosthetic Valves

Future Cardiology, 2010
Transcatheter valve implantation is becoming an alternative to conventional surgical valve replacement in patients at high surgical risk. While experience and acceptance with transcatheter techniques increased rapidly, transcatheter valve implantation within failing bioprostheses has emerged as a new concept (valve-in-valve implantation).
Ali N, Azadani, Elaine E, Tseng
openaire   +2 more sources

Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture

EuroIntervention, 2021
Bioprosthetic valve fracture (BVF) is a technique to reduce gradients in valve-in-valve transcatheter aortic valve implantation (VIV-TAVI) procedures. The outcome of VIV-TAVI with BVF has not been compared with VIV-TAVI without BVF.The aim of this study was to evaluate the outcome of VIV-TAVI with BVF compared to VIV-TAVI without BVF.In total, 81 cases
Brinkmann, Christina, Abdel-Wahab, Mohamed, Bedogni, Francesco, Bhadra, Oliver D., Charbonnier, Gaetan, Conradi, Lenard, Hildick-Smith, David, Kargoli, Faraj, Latib, Azeem, Van Mieghem, Nicolas M., Mylotte, Darren, Landes, Uri, Pilgrim, Thomas, Stripling, Jan, Taramasso, Maurizio, Tchétché, Didier, Testa, Luca, Thiele, Holger, Webb, John, Windecker, Stephan, Witt, Julian, Wohlmuth, Peter, Schofer, Joachim   +22 more
openaire   +2 more sources

Prosthetic Valves, Transcatheter Valves and Valve Repairs

2012
What to tell the surgeon Post-CPB: •Valve well seated •Leaflets mobile (2D and color Doppler) •Valvular functional leaks (washing jets, physiologic) •Paravalvular leaks (color Doppler) •Peak and mean valve pressure gradients •Effective orifice area (aortic valve) ??Obstruction LVOT (MV strut), SAM of AMVL (if AV prosthesis too small)
openaire   +1 more source

Outcomes of Valve-in-Valve Transcatheter Aortic Valve Replacement

The American Journal of Cardiology
Structural valve degeneration is increasingly seen given the higher rates of bioprosthetic heart valve use for surgical and transcatheter aortic valve replacement (TAVR). Valve-in-valve TAVR (VIV-TAVR) is an attractive alternate for patients who are otherwise at high risk for reoperative surgery.
Danial, Ahmad, Sarah, Yousef, Dustin, Kliner, James A, Brown, Derek, Serna-Gallegos, Catalin, Toma, Amber, Makani, David, West, Yisi, Wang, Floyd W, Thoma, Ibrahim, Sultan   +10 more
openaire   +2 more sources

Valve in Valve in Rapid Deployment Valves

The Thoracic and Cardiovascular Surgeon, 2020
F. Schröter, R. U. Kuehnel, M. Hartrumpf, R. Ostovar, J. Albes   +4 more
openaire   +1 more source

Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement

Circulation, 2021
Ran Kornowski, Harindra Wijeysundera, Ole De Backer   +2 more
exaly  

[Valve-in-valve with Portico valve for a degenerative bioprosthetic surgical valve (Biocor)].

Giornale italiano di cardiologia (2006), 2016
In the last years, a general shift toward the use of surgical bioprosthetic aortic valves rather than mechanical valves with subsequent less use of anticoagulant therapy has been observed. However, bioprosthetic valves have limited durability. Reoperation, the current standard of care for these patients, carries a high surgical risk, especially because
Roberto Adriano, Latini, Luca, Testa, Nedy, Brambilla, Maurizio, Tusa, Francesco, Bedogni   +4 more
openaire   +1 more source

Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves

Circulation, 2021
Marina Ureña, Eric Brochet, Gregory Ducrocq   +2 more
exaly